Which has higher valuation & earnings, ALVOW or APLMW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alvotech $491.95M N/A N/A N/A N/A Apollomics $8.50M N/A N/A N/A N/A

Is ALVOW or APLMW more profitable?

Company Net Margins Return on Equity Return on Assets Alvotech N/A N/A N/A Apollomics N/A N/A N/A

Which has stronger valuation and earnings, APLMW or ARAV?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Apollomics $8.50M N/A N/A N/A N/A Aravive N/A N/A N/A -$0.90 N/A

Is APLMW or ARAV more profitable?

Company Net Margins Return on Equity Return on Assets Apollomics N/A N/A N/A Aravive N/A N/A N/A

Which has better earnings & valuation, BIAFW or APLMW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio bioAffinity Technologies $5.85M N/A N/A N/A N/A Apollomics $8.50M N/A N/A N/A N/A

Is BIAFW or APLMW more profitable?

Company Net Margins Return on Equity Return on Assets bioAffinity Technologies N/A N/A N/A Apollomics N/A N/A N/A

Which has better valuation & earnings, BIVIW or APLMW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio BioVie N/A N/A N/A N/A N/A Apollomics $8.50M N/A N/A N/A N/A

Is BIVIW or APLMW more profitable?

Company Net Margins Return on Equity Return on Assets BioVie N/A N/A N/A Apollomics N/A N/A N/A

Which has stronger earnings & valuation, CDIOW or APLMW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cardio Diagnostics $14.45K N/A N/A N/A N/A Apollomics $8.50M N/A N/A N/A N/A

Is CDIOW or APLMW more profitable?

Company Net Margins Return on Equity Return on Assets Cardio Diagnostics N/A N/A N/A Apollomics N/A N/A N/A

Apollomics (APLMW) Competitors

$0.01 0.00 (0.00%)

As of 09/23/2026 11:16 AM Eastern

Compare

APLMW vs. ALVOW, ARAV, BIAFW, BIVIW, and CDIOW

Should you buy Apollomics stock or one of its competitors? Apollomics's main competitors and comparable companies include Alvotech (ALVOW), Aravive (ARAV), bioAffinity Technologies (BIAFW), BioVie (BIVIW), and Cardio Diagnostics (CDIOW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does Apollomics compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and Apollomics (NASDAQ:APLMW) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, risk, analyst recommendations and media sentiment.

In the previous week, Alvotech's average media sentiment score of 0.00 equaled Apollomics'average media sentiment score.

Company	Overall Sentiment
Alvotech	Neutral
Apollomics	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alvotech	$491.95M	N/A	N/A	N/A	N/A
Apollomics	$8.50M	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Alvotech	N/A	N/A	N/A
Apollomics	N/A	N/A	N/A

Summary

Alvotech beats Apollomics on 1 of the 1 factors compared between the two stocks.

How does Apollomics compare to Aravive?

Apollomics (NASDAQ:APLMW) and Aravive (NASDAQ:ARAV) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.

Company	Net Margins	Return on Equity	Return on Assets
Apollomics	N/A	N/A	N/A
Aravive	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apollomics	$8.50M	N/A	N/A	N/A	N/A
Aravive	N/A	N/A	N/A	-$0.90	N/A

In the previous week, Apollomics' average media sentiment score of 0.00 equaled Aravive'saverage media sentiment score.

Company	Overall Sentiment
Apollomics	Neutral
Aravive	Neutral

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Aravive beats Apollomics on 2 of the 3 factors compared between the two stocks.

How does Apollomics compare to bioAffinity Technologies?

bioAffinity Technologies (NASDAQ:BIAFW) and Apollomics (NASDAQ:APLMW) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, dividends, institutional ownership, profitability, media sentiment and earnings.

Company	Net Margins	Return on Equity	Return on Assets
bioAffinity Technologies	N/A	N/A	N/A
Apollomics	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
bioAffinity Technologies	$5.85M	N/A	N/A	N/A	N/A
Apollomics	$8.50M	N/A	N/A	N/A	N/A

In the previous week, bioAffinity Technologies had 2 more articles in the media than Apollomics. MarketBeat recorded 2 mentions for bioAffinity Technologies and 0 mentions for Apollomics. Apollomics' average media sentiment score of 0.00 beat bioAffinity Technologies' score of -0.73 indicating that Apollomics is being referred to more favorably in the news media.

Company	Overall Sentiment
bioAffinity Technologies	Negative
Apollomics	Neutral

Summary

Apollomics beats bioAffinity Technologies on 2 of the 3 factors compared between the two stocks.

How does Apollomics compare to BioVie?

BioVie (NASDAQ:BIVIW) and Apollomics (NASDAQ:APLMW) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, profitability, earnings, media sentiment, valuation, analyst recommendations, risk and institutional ownership.

Company	Net Margins	Return on Equity	Return on Assets
BioVie	N/A	N/A	N/A
Apollomics	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioVie	N/A	N/A	N/A	N/A	N/A
Apollomics	$8.50M	N/A	N/A	N/A	N/A

In the previous week, BioVie had 2 more articles in the media than Apollomics. MarketBeat recorded 2 mentions for BioVie and 0 mentions for Apollomics. BioVie's average media sentiment score of 0.82 beat Apollomics' score of 0.00 indicating that BioVie is being referred to more favorably in the media.

Company	Overall Sentiment
BioVie	Positive
Apollomics	Neutral

Summary

BioVie beats Apollomics on 2 of the 3 factors compared between the two stocks.

How does Apollomics compare to Cardio Diagnostics?

Cardio Diagnostics (NASDAQ:CDIOW) and Apollomics (NASDAQ:APLMW) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, risk, media sentiment and valuation.

Company	Net Margins	Return on Equity	Return on Assets
Cardio Diagnostics	N/A	N/A	N/A
Apollomics	N/A	N/A	N/A

In the previous week, Cardio Diagnostics' average media sentiment score of 0.00 equaled Apollomics'average media sentiment score.

Company	Overall Sentiment
Cardio Diagnostics	Neutral
Apollomics	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cardio Diagnostics	$14.45K	N/A	N/A	N/A	N/A
Apollomics	$8.50M	N/A	N/A	N/A	N/A

Summary

Apollomics beats Cardio Diagnostics on 1 of the 1 factors compared between the two stocks.

Get Apollomics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding APLMW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

APLMW vs. The Competition

Export

Metric	Apollomics	Biotechnology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	N/A	$3.98B	$7.31B	$13.28B
Dividend Yield	N/A	3.63%	2.52%	12.57%
P/E Ratio	N/A	13.88	274.10	25.70
Price / Sales	N/A	1,437.48	672.61	90.85
Price / Cash	N/A	113.29	77.80	52.76
Price / Book	N/A	15.45	10.48	6.32
Net Income	N/A	-$22.82M	$3.49B	$359.73M
7 Day Performance	N/A	-1.68%	-0.68%	0.17%
1 Month Performance	N/A	-6.15%	-3.18%	-3.27%
1 Year Performance	N/A	30.67%	15.13%	5.58%

Apollomics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
APLMW Apollomics	N/A	$0.01 flat	N/A	-39.3%	$0.00	$8.50M	N/A	59
ALVOW Alvotech	N/A	$0.37 flat	N/A	-81.9%	$0.00	$491.95M	N/A	4	High Trading Volume
ARAV Aravive	N/A	$0.04 flat	N/A	N/A	$0.00	N/A	N/A	20	High Trading Volume
BIAFW bioAffinity Technologies	N/A	$0.31 +5.2%	N/A	+284.4%	$0.00	$5.85M	N/A	10	News Coverage Gap Down
BIVIW BioVie	N/A	$0.33 +10.2%	N/A	N/A	$0.00	N/A	N/A	N/A	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:APLMW) was last updated on 9/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Apollomics (APLMW) Competitors